INTRODUCTION

Antimicrobials are a cornerstone of modern public health; however, the increasing prevalence of antimicrobial resistance (AMR), particularly in the livestock sector, poses a serious threat to the effectiveness of infectious disease therapy in both animals and humans [1, 2]. Poorly managed dairy farm waste represents a major source for the dissemination of antibiotic-resistant bacteria (ARB) [3]. Such waste frequently contains high concentrations of Escherichia coli harboring antibiotic resistance genes associated with antimicrobial use in veterinary production systems [4]. E. coli isolated from dairy cow waste has been shown to exhibit resistance to multiple antibiotic classes, including tetracyclines, beta-lactams, macrolides, and aminoglycosides [5, 6]. The presence of ARB in agricultural waste is not only indicative of on-farm management challenges but also constitutes a significant environmental and public health risk [7].

Conventional wastewater treatment systems are frequently inadequate for the effective inactivation of ARB [8], highlighting the urgent need for alternative control strategies. Silver nanoparticles (AgNPs) have demonstrated broad-spectrum antibacterial activity against a wide range of pathogenic bacteria, including antibiotic-resistant strains, under both in vitro and in vivo conditions [9, 10]. The antimicrobial activity of AgNPs is mediated by multiple nonspecific mechanisms, including disruption of bacterial cell membranes, induction of oxidative stress, and interference with essential intracellular biochemical processes, thereby limiting bacteria’s ability to develop resistance [11, 12]. The inhibitory and bactericidal effects of AgNPs against E. coli have been consistently reported [13–15].

In the present study, AgNPs were synthesized using pulsed laser ablation (PLA) in liquid, a technique that offers distinct advantages over conventional chemical synthesis approaches. PLA enables the production of AgNPs with very high-purity (>99%) without residual chemical contaminants, such as reducing agents, stabilizers, or capping agents, which are commonly associated with chemical synthesis and may interfere with antimicrobial assessment [16]. In addition, PLA-derived AgNPs exhibit uniform particle size, high surface reactivity, sustainability, and long-term colloidal stability. Consequently, PLA was selected as the most appropriate method to generate AgNPs with optimal characteristics for reliable antimicrobial evaluation against antibiotic-resistant E. coli isolates originating from livestock waste [17].

The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) are critical parameters for determining effective antimicrobial doses and are widely used to assess the in vitro efficacy of AgNPs against pathogenic isolates from livestock waste, particularly E. coli [10]. Continued refinement of AgNP synthesis methods and evaluation at biologically relevant concentrations is expected to contribute to novel strategies for controlling ARB in the livestock sector and reducing the environmental and public health risks associated with AMR dissemination [9, 18].

Despite growing evidence supporting the antimicrobial potential of AgNPs against ARB, several critical gaps remain in the context of livestock-associated environmental contamination. Most existing studies rely on chemically synthesized or biologically derived AgNPs, which may contain residual reagents that confound antimicrobial assessment and limit reproducibility. In addition, many investigations use reference strains rather than field-derived ARB, reducing real-world relevance. Data on the in vitro efficacy of high-purity, PLA-synthesized AgNPs against antibiotic-resistant E. coli originating specifically from dairy farm wastewater are scarce. Moreover, comparative evaluations of MIC and MBC across different antibiotic resistance profiles of E. coli isolates remain limited, hindering the identification of an optimal inhibitory concentration applicable to heterogeneous resistance patterns. This lack of integrated evidence impedes the translation of AgNP-based interventions into practical livestock waste management strategies to mitigate AMR dissemination within a One Health framework.

Therefore, this study aimed to evaluate the in vitro antimicrobial efficacy of PLA-synthesized AgNPs against antibiotic-resistant E. coli isolated from dairy farm wastewater. Specifically, the study sought to determine and compare the MIC and MBC values of AgNPs across E. coli isolates exhibiting resistance to different antibiotic classes, and to identify an effective inhibitory concentration applicable across resistance profiles. By using high-purity, chemically uncontaminated AgNPs and field-derived isolates, this work aims to provide robust evidence supporting the potential application of AgNPs as a complementary control strategy for ARB in dairy waste systems and to contribute to AMR mitigation efforts under a One Health approach.

MATERIALS AND METHODS

Ethical approval

This study was approved by the Ethical Clearance Committee of the Faculty of Veterinary Medicine, Universitas Wijaya Kusuma Surabaya, Indonesia (Ethics number: 97-KKE/2025). All procedures were conducted in accordance with institutional ethical guidelines for microbiological research and environmental sampling. The collection, transportation, and handling of dairy farm wastewater samples followed established institutional biosafety protocols and relevant national regulations in Indonesia.

Study period and location

The study was conducted from June to August 2025 at the Veterinary Public Health Laboratory, Faculty of Veterinary Medicine, Universitas Wijaya Kusuma Surabaya, Indonesia.

Research design

A cross-sectional study was conducted to evaluate the antimicrobial effectiveness of AgNPs synthesized using PLA against antibiotic-resistant E. coli isolates obtained from dairy cow waste in the livestock area of Grati District, Pasuruan Regency, East Java.

Sample collection

Wastewater samples (5 mL per farm) were collected from 50 smallholder dairy farms housing approximately 2–10 dairy cows each. Samples were obtained directly from drainage channels or wastewater storage tanks using sterile pipettes. To minimize external contamination, sampling was performed at a depth of 5–10 cm below the wastewater surface under aseptic conditions. Each sample was labeled with farm identity, date, time, and environmental conditions. All samples (n = 50) were transported to the laboratory in insulated containers with ice packs maintained at 4°C and processed within 2 h of collection.

Synthesis of AgNPs using PLA

AgNPs were synthesized from silver metal plates, 5 × 10 × 20 mm³, 99.9% purity (Sigma-Aldrich, St. Louis, MO, USA), using polyvinylpyrrolidone (PVP) (Merck KGaA, Darmstadt, Germany) as the liquid medium. An Nd:YAG laser, 1064 nm wavelength, 7 ns pulse width, 20 Hz (Polaris II, New Wave Research, Fremont, CA, USA) was used as the radiation source, with laser parameters controlled using LaserExec II software (New Wave Research, Fremont, CA, USA). The laser energy was set at 30 mJ with a repetition rate of 10 Hz. Characterization was performed using a ultraviolet–visible (UV–Vis) spectrophotometer (Shimadzu Corporation, Kyoto, Japan), transmission electron microscopy (TEM; JEOL Ltd, Tokyo, Japan) coupled with energy-dispersive X-ray spectro-scopy, and Fourier transform infrared spectroscopy (FTIR) (Shimadzu Corporation, Kyoto, Japan) [19].

During synthesis, the laser beam was directed by a silver mirror and focused through a quartz lens (30 mm focal length) onto the silver target immersed in a liquid medium in a Petri dish for 11 h. The solution color gradually changed from transparent to light yellow and then to brownish yellow with increasing laser exposure. TEM, particle size analysis, UV–Vis spectrophotometer, and FTIR spectroscopy were used to assess morphology, particle size distribution, optical plasmon resonance, and surface chemistry [19]. The AgNP suspension was stored in sealed amber glass bottles at 4°C–8°C to maintain stability and prevent aggregation. Only a single batch was used in this study. The freshly synthesized AgNP colloid was diluted in sterile 0.9% NaCl to obtain an initial stock concentration of 1000 ppm.

Isolation and identification of E. coli

Wastewater samples (1 mL) were inoculated into 9 mL of buffered peptone water (Himedia, Mumbai, India) and incubated at 37°C for 18–24 h for pre-enrichment. Subsequently, 0.1 mL of enriched culture was streaked onto MacConkey agar (Oxoid, Basingstoke, UK) and incubated at 37°C for 18–24 h under aerobic conditions. Lactose-fermenting colonies exhibiting pink to red coloration, smooth surface, round shape, and convex edges were selected for further analysis. Presumptive E. coli isolates were confirmed using morphological examination, Gram staining, and standard biochemical tests (Indole, methyl red, Voges–Proskauer, citrate) [20, 21].

Antimicrobial susceptibility testing (AST)

Confirmed E. coli isolates were subjected to AST using the Kirby–Bauer disk diffusion method in accordance with Clinical and Laboratory Standards Institute (CLSI) M100, 34th edition standards [22]. Four antibiotic disks (Oxoid) were used for screening: penicillin (10 IU/disk), streptomycin (10 µg/disk), erythromycin (15 µg/disk), and tetracycline (30 µg/disk). Resistance breakpoints were defined as ≤11 mm for streptomycin and tetracycline, and ≤13 mm for penicillin, according to the CLSI 2024 guidelines [22]. As E. coli is not routinely tested for erythromycin under CLSI standards, a general resistance cutoff of ≤13 mm was applied. A total of 20 antibiotic-resistant E. coli isolates (five per antibiotic category) were selected for MIC and MBC assays [22, 23]. E. coli ATCC 25922 (Oxoid) was used as the quality control strain.

Determination of MIC

Bacterial inocula were prepared by culturing selected E. coli isolates in Mueller–Hinton broth (MHB) (Oxoid, Basingstoke, UK) at 37°C for 18 h with agitation at 150 rpm until an OD₆₀₀ of 0.5–0.6 McFarland standard was achieved, corresponding to approximately 1.5 × 10⁸ CFU/mL. MIC determination was performed using the broth microdilution method according to CLSI M07-A8 guidelines [24]. Serial twofold dilutions of AgNPs (100–0.195 ppm) were prepared in 96-well microplates (OneMed, Sidoarjo, Indonesia) containing MHB inoculated with standardized bacterial suspensions (10⁸ CFU/mL). Plates were incubated at 37°C for 24 h. The MIC endpoint was defined as the lowest AgNP concentration showing no visible bacterial growth, as assessed by visual turbidity before and after incubation. Negative and positive controls were included, and all assays were performed in duplicate.

Determination of MBC

MBC determination was conducted using the conventional agar diffusion method. Aliquots (10 µL) from MIC wells without visible growth were spread onto Mueller–Hinton agar (Himedia) plates and incubated at 37°C for 24 h. The MBC endpoint was defined as the lowest AgNP concentration resulting in the complete absence of bacterial growth on agar plates, indicating total bacterial killing [25]. All tests were performed in duplicate.

Statistical analysis

MIC and MBC values were analyzed using one-way analysis of variance followed by Tukey’s multiple comparison test to identify differences among antibiotic resistance groups. Statistical significance was set at p < 0.05. All analyses were performed using IBM SPSS Statistics version 29 (IBM Corp., Armonk, NY, USA).

RESULTS

Characterization of AgNPs

AgNPs were successfully synthesized using PLA in PVP media and demonstrated excellent physicochemical characteristics. TEM analysis of 247 particles showed an average particle diameter of 11.62 ± 1.8 nm, with a coefficient of variation of 15.5%, indicating a narrow and monodisperse size distribution. UV–Vis spectrophoto-meter revealed a distinct surface plasmon resonance peak at 418 nm with an absorbance intensity of 0.786 AU, confirming the formation of metallic silver without detectable silver oxide contamination. FTIR analysis verified the presence of PVP K30 as a capping and stabilizing agent on the AgNP surface, characterized by a strong peak at 1680 cm^-1 (C = O stretching) and additional peaks at 2950, 1550, and 1250 cm^-m, indicating an intact PVP backbone without degradation. The estimated coating thickness of approximately 2.6 nm contributed to colloidal stability. Overall, the synthesized AgNPs exhibited high purity, uniform morphology, and stability, making them suitable for subsequent antimicrobial evaluation (MIC/MBC) against antibiotic-resistant E. coli isolates from dairy cow waste.

Antimicrobial activity against antibiotic-resistant E. coli

The antimicrobial activity of AgNPs was evaluated against antibiotic-resistant E. coli isolates recovered from dairy cattle waste. The isolates comprised streptomycin-resistant (S1–S5), erythromycin-resistant (E1–E5), penicillin-resistant (P1–P5), and tetracycline-resistant (T1–T5) groups.

Figure 1 presents the MIC results determined using the standard broth microdilution method. Following MIC determination, MBC assessment was performed by subculturing wells without visible growth onto Mueller–Hinton agar. As illustrated in Figure 2, AgNPs exerted a bactericidal effect at 100 ppm against isolate P1, whereas isolate P2 continued to grow at the same concentration.

Results of the minimum inhibitory concen-tration assay of silver nanoparticles against antibiotic-resistant Escherichia coli were determined using the standard broth microdilution method. K− indicates the negative control with no bacterial growth (clear wells), whereas K+ indicates the positive control with bacterial growth (turbid wells).

Results of the minimum bactericidal concentration assay of silver nanoparticles against antibiotic-resistant Escherichia coli determined using the conventional agar diffusion method on Mueller–Hinton agar. P denotes penicillin-resistant isolates.

MIC and MBC distribution among resistance groups

The MIC and MBC values for all antibiotic-resistant E. coli isolates tested against AgNPs are summarized in Table 1. MIC values ranged from 37.5 to 100 ppm across all isolates. In contrast, MBC values were generally higher, with most isolates exhibiting MBC values exceeding 100 ppm, the highest concentration tested in this study. These findings indicate that AgNPs exerted a strong inhibitory (bacteriostatic) effect but comparatively weaker bactericidal activity against antibiotic-resistant E. coli isolated from dairy cattle waste.

AgNPs = Silver nanoparticles, MIC = Minimum inhibitory concentration, MBC = Minimum bactericidal concentration, CLSI = Clinical and Laboratory Standards Institute. Values >100 ppm indicate no bactericidal activity at the highest concentration tested.

After 24 h of incubation, streptomycin-resistant E. coli required the highest AgNP concentrations for growth inhibition, with MIC values ranging from 62.5 to 100 ppm. In contrast, erythromycin-resistant E. coli showed the lowest MIC values among the resistance groups, ranging from 37.5 to 50 ppm. Across all isolates, MBC values exceeded corresponding MIC values and ranged between 100 and >100 ppm. Overall, 75% (15/20) of the isolates exhibited MBC values >100 ppm. Only five isolates showed an MBC of 100 ppm, comprising three erythromycin-resistant and two penicillin-resistant E. coli isolates. Due to the predominance of MBC values >100 ppm, further MBC interpretation was limited to descriptive analysis.

Comparative statistical analysis of MIC values

One-way ANOVA followed by Tukey’s multiple comparison test revealed no statistically significant differences in mean MIC values among the antibiotic resistance groups (F (3,36) = 2.20; p = 0.105). Post hoc Tukey’s Honestly Significant Differences analysis confirmed that none of the pairwise comparisons reached statistical significance (p > 0.05). Descriptively, streptomycin-resistant isolates exhibited the highest mean MIC values (75.0 ± 33.3 ppm), whereas erythromycin-resistant isolates showed the lowest mean MIC values with the narrowest variability (45.0 ± 10.5 ppm). These data are presented in Table 2.

AgNPs = Silver nanoparticles, MBC = Minimum bactericidal concentration, SD = Standard deviation. Values represent ppm.

Identification of the most effective inhibitory concentration

The lowest MIC value observed was 37.5 ppm, which inhibited erythromycin-resistant E. coli isolates (E2 and E5), one penicillin-resistant isolate (P2), and one tetracycline-resistant isolate (T3). At this concentration, streptomycin-resistant E. coli isolates were not inhibited (Figure 3). Growth inhibition of streptomycin-resistant isolates was first observed at an MIC of 62.5 ppm. Therefore, 62.5 ppm was identified as the most effective concentration for consistently inhibiting the growth of antibiotic-resistant E. coli isolated from dairy cattle waste across resistance profiles.

Minimum inhibitory concentration of silver nanoparticles against antibiotic-resistant Escherichia coli. Data bars represent the mean of duplicate measurements for each isolate. S = Streptomycin-resistant, E = Erythromycin-resistant, P = Penicillin-resistant, T = Tetracycline-resistant.

DISCUSSION

Antimicrobial efficacy of AgNPs against antibiotic-resistant E. coli

AgNPs have been extensively investigated as alternative antimicrobial agents against ARB due to their broad-spectrum activity. In the present study, the antimicrobial efficacy of AgNPs was evaluated against E. coli isolates resistant to streptomycin, erythromycin, penicillin, and tetracycline recovered from dairy cow waste. The observed MIC values ranged from 37.5 to 100 ppm, indicating effective growth inhibition within this concentration range. A serial twofold dilution assay (100–0.195 ppm) using a standardized bacterial inoculum of 10⁸ CFU/mL was applied, consistent with commonly adopted nanomaterial antimicrobial testing protocols, thereby ensuring data reliability and comparability with previous studies [26, 27].

Variation in MIC among resistance phenotypes

The lowest MIC values were recorded for erythromycin-resistant E. coli (37.5–50 ppm), whereas streptomycin-resistant isolates required higher AgNP concentrations (62.5–100 ppm) for growth inhibition [28]. These differences likely reflect variability in resistance mechanisms, including efflux pump activity or antibiotic target modifications, which may also influence nanoparticle–cell interactions [27]. Streptomycin-resistant E. coli may possess enhanced protective mechanisms against metal nanoparticles, such as altered membrane permeability or more efficient efflux systems, reducing nanoparticle penetration and intracellular accumulation [29, 30].

Statistical comparison of inhibitory effects

One-way ANOVA followed by Tukey’s multiple comparison test showed no statistically significant differences in MIC values among the antibiotic resistance groups, indicating that variations in AgNP concentration within the tested range did not significantly alter overall inhibitory efficacy. This suggests a relatively narrow effective concentration window for AgNP-mediated growth inhibition, within which concentration-dependent differences are not statistically distinguishable [31]. Streptomycin-resistant E. coli required an MIC of 62.5 ppm for inhibition, whereas erythromycin-, penicillin-, and tetracycline-resistant isolates were inhibited at concentrations below 62.5 ppm. Accordingly, 62.5 ppm was identified as the most effective concentration for consistent inhibition of antibiotic-resistant E. coli isolated from dairy cattle waste.

Bacteriostatic versus bactericidal activity

MBC values exceeded MIC values for most isolates and frequently surpassed the maximum tested concentration of 100 ppm, indicating limited bactericidal activity under the conditions tested. These findings support the notion that AgNPs primarily exert a bacteriostatic effect against these isolates rather than direct bactericidal action [32]. Similar observations have been reported previously, where bacterial survival and metabolic activity persisted under sublethal AgNP exposure, suggesting that higher concentrations or combination strategies may be required to achieve complete bacterial killing [33]. The antimicrobial mechanisms of AgNPs, including membrane disruption, Reactive oxygen species (ROS) generation, and interactions with proteins and DNA, contribute to growth inhibition and, at higher doses, cell death [34].

Influence of biofilm formation and heteroresistance

Bacterial biofilm formation and antibiotic resistance profiles play a critical role in determining sensitivity to AgNPs. Biofilm-producing bacteria exhibit increased resistance due to the extracellular matrix acting as a physical barrier that limits nanoparticle penetration, along with adaptive responses such as upregulation of efflux pump–related genes associated with metal resistance [35, 36]. These adaptations may promote cross-resistance to both antibiotics and AgNPs, highlighting the need for combination therapies or biofilm-targeted approaches [37, 38]. The substantial variability in MIC values observed within resistance groups can be attributed to multiple interacting factors, including heterogeneous resistance mechanisms, media-induced changes in AgNP stability and Ag⁺ ion availability [39], intrinsic heteroresistance within bacterial populations [40], and differences in biofilm-forming capacity among isolates [41].

Mechanisms of action and adaptive responses

AgNPs exert antimicrobial activity through ROS generation, membrane damage, increased permeability, and interference with bacterial proteins and DNA. Because these mechanisms differ from the specific targets of conventional antibiotics, AgNPs generally remain effective against ARB and present a lower risk of resistance development [26, 42]. Nevertheless, adaptive resistance may emerge through mutations affecting efflux systems, membrane proteins, and stress response pathways following prolonged AgNP exposure [43, 44].

Impact of nanoparticle aggregation on antimicrobial activity

The relatively high MIC values observed in this study may be partly explained by AgNP aggregation within the PVP matrix. Although PVP enhances colloidal stability, it may reduce Ag⁺ ion release and diminish antimicrobial efficacy. Under biorelevant conditions, AgNPs may aggregate to the micron scale, substantially reducing biological activity by decreasing surface area and particle–cell contact [45]. Previous studies have demonstrated that aggregation can alter MIC values by up to two orders of magnitude [46]. The MIC range observed here (37.5–100 ppm) is consistent with this phenomenon, as non-aggregated AgNPs of similar size typically exhibit MICs in the μg/mL range. Reduced Ag⁺ bioavailability, limited particle–bacteria interactions, and heterogeneous surface properties likely contributed to the predominance of MBC values >100 ppm and the identification of 62.5 ppm as the optimal inhibitory concentration [45–47].

Comparative performance and formulation optimization

The effectiveness of AgNPs compared with conventional antibiotics highlights their potential as alternative antimicrobial agents against antibiotic-resistant E. coli. However, these findings also underscore the need for improved nanoparticle formulations or synergistic combinations with antibiotics to enhance bactericidal activity [28, 48]. Strategies to overcome aggregation include replacing PVP with alternative stabilizers such as dextran or plant-derived compounds, or applying surface coatings such as polydopamine or mesoporous silica to improve Ag⁺ release and antimicrobial performance [41, 49]. Such approaches have been shown to reduce MIC values to more competitive ranges (5–20 ppm) [39].

Comparison with published studies

In this study, AgNPs effectively inhibited the growth of 20 antibiotic-resistant E. coli isolates from dairy farm waste, with MIC values ranging from 37.5 to 100 ppm. Erythromycin-resistant isolates exhibited the highest sensitivity, whereas streptomycin-resistant isolates required higher concentrations, reflecting heterogeneous resistance patterns. These MIC values are comparable to or lower than those reported in several published studies [50, 51]. For example, Trzcińska-Wencel et al. [50] reported MIC values of 16–64 μg/mL against E. coli ATCC with MBCs of 32–512 μg/mL, while Tufail et al. [51] reported MICs of 3.3–3.6 μg/mL for biogenic AgNPs. Rana et al. [52] reported an MIC of 1 mg/mL against E. coli MTCC 1698. The MIC values observed here (0.0375–0.1 mg/mL) are particularly noteworthy given that they were obtained using field-derived antibiotic-resistant isolates rather than more susceptible reference strains.

Practical implications and One Health relevance

Evaluating E. coli isolates from dairy cow waste has direct relevance to veterinary medicine and livestock waste management. The application of antimicrobial agents such as AgNPs in waste treatment systems may reduce environmental dissemination of resistant bacteria and limit exposure risks to animals and humans. However, further research is required to optimize dosing strategies while considering long-term environmental safety and potential nanoparticle residues in animal products [53, 54].

This study aligns strongly with the One Health framework, which integrates human, animal, and environmental health. Dairy cattle waste represents a significant reservoir of ARB capable of transmission through multiple environmental pathways [55, 56]. Inadequately treated agricultural waste can contaminate soil, surface water, and drinking water sources, posing sustained public health risks [57, 58]. The demonstrated antimicrobial activity of AgNPs against antibiotic-resistant E. coli supports the role of nanotechnology in strengthening One Health–based AMR mitigation strategies, particularly by reducing pathogen spillover from livestock systems to the wider human population [59]. By identifying 62.5 ppm as an effective inhibitory concentration across resistance profiles, this study offers a scalable technological option for integration into modern livestock waste management and cross-sectoral AMR risk reduction programs [60].

CONCLUSION

This study demonstrated that PLA-synthesized AgNPs effectively inhibited the growth of antibiotic-resistant E. coli isolated from dairy cattle waste. The MIC values ranged from 37.5 to 100 ppm, with erythromycin-resistant isolates showing the highest sensitivity (37.5–50 ppm) and streptomycin-resistant isolates requiring higher concentrations (62.5–100 ppm). Most isolates exhibited MBC values >100 ppm, indicating that AgNPs predominantly exerted a bacteriostatic rather than bactericidal effect under the tested conditions. Statistical analysis revealed no significant differences in MIC values among resistance groups (p > 0.05), and 62.5 ppm was identified as the most effective concentration for consistent growth inhibition across resistance profiles.

The observed inhibitory efficacy of AgNPs against antibiotic-resistant E. coli supports their potential application as a supplementary control measure in dairy waste management systems. Incorporation of AgNP-based treatments as a pre-treatment or polishing step in wastewater handling may reduce the environmental dissemination of ARB and lower exposure risks for livestock and surrounding communities. These findings are particularly relevant for resource-limited settings where conventional wastewater treatment methods are insufficient.

Key strengths include the use of high-purity, PLA-synthesized AgNPs free from chemical synthesis residues and the evaluation of field-derived antibiotic-resistant E. coli isolates rather than reference strains. The comprehensive assessment of MIC and MBC across multiple resistance phenotypes enhances the real-world relevance of the findings within a livestock and environmental health context.

This study was limited to in vitro testing under controlled laboratory conditions and did not assess AgNP performance in complex wastewater matrices or field-scale systems. The predominance of MBC values >100 ppm indicates limited bactericidal activity at the concentrations tested. In addition, potential environmental impacts, nanoparticle persistence, and toxicity to non-target organisms were not evaluated.

Future research should focus on optimizing AgNP formulations to enhance bactericidal efficacy, including surface modification, alternative stabilizers, or synergistic combinations with antibiotics or other antimicrobials. Evaluation of AgNP performance in real wastewater systems, assessment of long-term environmental safety, and investigation of resistance development under prolonged exposure are also warranted. Integration of AgNP-based interventions into holistic AMR mitigation strategies should be explored within a One Health framework.

Overall, PLA-synthesized AgNPs represent a promising non-antibiotic approach for inhibiting antibiotic-resistant E. coli in dairy cattle waste. By identifying 62.5 ppm as an effective inhibitory concentration across resistance profiles, this study provides a scientific basis for the potential integration of nanotechnology-based solutions into livestock waste management and AMR risk reduction strategies.

DATA AVAILABILITY

All the generated data are included in the manuscript.

AUTHORS’ CONTRIBUTIONS

SMY, MHE, and ARK: Conceptualization. WW, MHE, SMY, and RZA: methodology. JYHT, SR, and FJW: Formal analysis. TU, WW, and ARK: Investigation. JYHT, WW, RZA, and FJW: Data curation. TU and ARK: Visualization. FNAEPD, RZA, MHE, and WW: Validation. SMY, ARK, and MHE: Writing-original draft preparation. SMY, MHE, JYHT, FJW, TU, ARK, WW, RZA, FNAEPD, and SR: Writing-review and editing. SMY, ARK, MHE, and RZA: Supervision. All authors have read, critically reviewed, and approved the final manuscript, and agreed to be accountable for all aspects of the work.

COMPETING INTERESTS

The authors declare that they have no competing interests.

PUBLISHER’S NOTE

Veterinary World remains neutral with regard to jurisdictional claims in the published institutional affiliations.

ACKNOWLEDGMENTS

This research was supported by the Penelitian Research Group Fakultas Tahun 2025 with research contract number 2989/B/UN3.FKH/PT.01.03/2025.

REFERENCES

1. Sobur M, Sabuj AAM, Sarker RK, Rahman A, Kabir S, Rahman M. Antibiotic-resistant Escherichia coli and Salmonella spp. associated with dairy cattle and farm environment having public health significance. Vet World 2019;12(7):984. [Google Scholar] | [Crossref]
2. Yanestria SM, Dameanti FNAEP, Musayannah BG, Pratama JWA, Witaningrum AM, Effendi MH, Ugbo EN. Antibiotic resistance pattern of extended-spectrum β-lactamase (ESBL) producing Escherichia coli isolated from broiler farm environment in Pasuruan district, Indonesia. Biodiversitas 2022;23(9):4460-4465. [Google Scholar] | [Crossref]
3. Wang H, Gao Y, Zheng L, Ji L, Kong X, Du J, Wang H, Duan L, Niu T, Liu J, Shang M. Identification and distribution of antibiotic resistance genes and antibiotic resistance bacteria in the feces treatment process:a case study in a dairy farm, China. Water 2024;16(11):1575. [Google Scholar] | [Crossref]
4. Xu C, Kong L, Gao H, Cheng X, Wang X. A review of current bacterial resistance to antibiotics in food animals. Front Microbiol 2022;13(1):822689. [Google Scholar] | [Crossref]
5. Ahmed S, Hossain MI, Hossan T, Islam K, Uddin B, Rahman M, Hossain MA. The central cattle breeding and dairy farm, Bangladesh waste contributes in emergence and spread of aminoglycoside-resistant bacteria. Adv Biosci Biotechnol 2013;4(2):278-282. [Google Scholar] | [Crossref]
6. Tempini P, Aly S, Karle B, Pereira R. Multidrug residues and antimicrobial resistance patterns in waste milk from dairy farms in central California. J Dairy Sci 2018;101(9):8110-8122. [Google Scholar] | [Crossref]
7. Arbab S, Ullah H, Wang W, Li K, Akbar A, Zhang J. Isolation and identification of infection-causing bacteria in dairy animals and determination of their antibiogram. J Food Qual 2021;2021(1):2958304. [Google Scholar] | [Crossref]
8. Barancheshme F, Munir M. Strategies to combat antibiotic resistance in the wastewater treatment plants. Front Microbiol 2018;8(1):2603. [Google Scholar] | [Crossref]
9. Xin X, Qi C, Xu L, Gao Q, Liu X. Green synthesis of silver nanoparticles and their antibacterial effects. Front Chem Eng 2022;4(1):941240. [Google Scholar] | [Crossref]
10. El-Gohary FA, AbdelHafez LJM, Zakaria AI, Shata RR, Tahoun A, ElMleeh A, Elfadl EAA, Elmahallawy EK. Enhanced antibacterial activity of silver nanoparticles combined with hydrogen peroxide against multidrug-resistant pathogens isolated from dairy farms and beef slaughterhouses in Egypt. Infect Drug Resist 2020;13(1):3485-3499. [Google Scholar] | [Crossref]
11. Dakal TC, Kumar A, Majumdar RS, Yadav V. Mechanistic basis of antimicrobial actions of silver nanoparticles. Front Microbiol 2016;7(1):1831. [Google Scholar] | [Crossref]
12. Kdziora A, Speruda M, Krzyewska E, Rybka J, Łukowiak A, Bugla-Płoskońska G. Similarities and differences between silver ions and silver in nanoforms as antibacterial agents. Int J Mol Sci 2018;19(2):444. [Google Scholar] | [Crossref]
13. Loo YY, Rukayadi Y, NorKhaizura MAR, Kuan C, Chieng BW, Nishibuchi M, Radu S. In vitro antimicrobial activity of green-synthesized silver nanoparticles against selected Gram-negative foodborne pathogens. Front Microbiol 2018;9(1):1555. [Google Scholar] | [Crossref]
14. Raja FNS, Worthington T, Martin RA. The antimicrobial efficacy of copper, cobalt, zinc and silver nanoparticles:alone and in combination. Biomed Mater 2023;18(4):045003. [Google Scholar] | [Crossref]
15. Ali AR, Anani HAA, Selim F. Biologically formed silver nanoparticles and in vitro study of their antimicrobial activities on resistant pathogens. Iran J Microbiol 2021;13(6):848. [Google Scholar] | [Crossref]
16. Salim ET, Saimon JA, Muhsin MS, Fakhri MA, Amin MH, Azzahrani AS, Ibrahim RK. Mesoporous Ag@WO3 core–shell:an investigation at different concentrated environment employing laser ablation in liquid. Sci Rep 2024;14(1):5473. [Google Scholar] | [Crossref]
17. Ajose DJ, Abolarinwa TO, Oluwarinde BO, Montso PK, Fayemi OE, Aremu AO, Ateba CN. Application of plant-derived nanoparticles (pdnp) in food-producing animals as a bio-control agent against antimicrobial-resistant pathogens. Biomedicines 2022;10((10)):2426. [Google Scholar] | [Crossref]
18. Widodo A, Lamid M, Effendi MH, Khairullah AR, Kurniawan SC, Silaen OSM, Riwu KHP, Yustinasari LR, Afnani DA, Dameanti FNAEP, Ramandinianto SC. Antimicrobial resistance characteristics of multidrug resistance and extended-spectrum beta-lactamase-producing Escherichia coli from several dairy farms in Probolinggo, Indonesia. Biodiversitas Journal of Biological Diversity 2023;24(1):215-221. [Google Scholar] | [Crossref]
19. Avicenna S, Nurhasanah I, Khumaeni A. Synthesis of colloidal silver nanoparticles in various liquid media using pulse laser ablation method and its antibacterial properties. Indones J Chem 2021;21(3):761-768. [Google Scholar] | [Crossref]
20. Gondal AJ, Choudhry N, Bukhari H, Rizvi Z, Yasmin N. Characterization of genomic diversity among carbapenem-resistant Escherichia coli clinical isolates and antibacterial efficacy of silver nanoparticles from Pakistan. Microorganisms 2022;10(11):2283. [Google Scholar] | [Crossref]
21. Dameanti FNAEP, Yanestria SM, Effendi MH, Plumeriastuti H, Tyasningsih W, Ugbo EN, Safri MAA. Genotyping of extended-spectrum beta-lactamase-producing Escherichia coli isolated from wastewater of dairy farms in East Java, Indonesia. Vet World 2025;18(1):162. [Google Scholar] | [Crossref]
22. Performance standards for antimicrobial susceptibility testing. Wayne (PA): CLSI; 2024. [Google Scholar]
23. Yanestria SM, Effendi MH, Tyasningsih W, Khairullah AR, Kurniawan SC, Moses IB, Hasib A. Fluoroquinolone resistance and phylogenetic analysis of broiler Campylobacter jejuni isolates in Indonesia. J Adv Vet Res 2024;14((1)):204-208. [Google Scholar] | [Crossref]
24. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. Wayne (PA): CLSI; 2009. [Google Scholar]
25. Parvekar P, Palaskar J, Metgud S, Maria R, Dutta S. The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of silver nanoparticles against Staphylococcus aureus. Biomater Investig Dent 2020;7(1):105-109. [Google Scholar] | [Crossref]
26. Menichetti A, Mavridi-Printezi A, Mordini D, Montalti M. Effect of size, shape and surface functionalization on the antibacterial activity of silver nanoparticles. J Funct Biomater 2023;14(5):244. [Google Scholar] | [Crossref]
27. Bello ET, Awe S, Bale MI, Awosika A, Oladejo JM, Olaitan FJ, Olaitan F. Antibacterial activity of phyto-synthesized silver nanoparticles from Dryopteris cristata against Staphylococcus aureus ATCC 28923 and Escherichia coli ATCC 28922. Cureus 2024;16(10):e70856. [Google Scholar] | [Crossref]
28. Kazemnia A, Ahmadi M, Mardani K, Moradi M, Darvishzadeh R. Combined efficacy of silver nanoparticles and commercial antibiotics on different phylogenetic groups of Escherichia coli. J Hellenic Vet Med Soc 2019;70(3):1647-1654. [Google Scholar] | [Crossref]
29. Niño-Martínez N, Salas Orozco MF, Martínez-Castañón GA, Méndez FT, Ruiz F. Molecular mechanisms of bacterial resistance to metal and metal oxide nanoparticles. Int J Mol Sci 2019;20(11):2808. [Google Scholar] | [Crossref]
30. Abdulraof LAA, Naser HH. Synergistic antimicrobial activity of a novel synthetic peptide and silver nanoparticles against multidrug-resistant Ecoli. Int J Environ Sci 2025;11((12 Suppl)):828-853. [Google Scholar] | [Crossref]
31. Pathak P, Pandit VA, Dhande PP. Bioequivalence of generic and branded amoxicillin capsules in healthy human volunteers. Indian J Pharmacol 2017;49(2):176-181. [Google Scholar] | [Crossref]
32. Pedreira A, Vázquez JA, García MR. Kinetics of bacterial adaptation, growth, and death at didecyldimethylammonium chloride sub-MIC concentrations. Front Microbiol 2022;13(1):758237. [Google Scholar] | [Crossref]
33. Şirin MC, Cezaroğlu Y, Çetin ES, Arıdoğan B, Trak D, Arslan Y. Antibacterial and antibiofilm efficacy of colistin and meropenem conjugated silver nanoparticles against Escherichia coli and Klebsiella pneumoniae. J Basic Microbiol 2023;63(12):1397-1411. [Google Scholar] | [Crossref]
34. Liao S, Zhang Y, Pan X, Zhu F, Jiang C, Liu Q, Chen L. Antibacterial activity and mechanism of silver nanoparticles against multidrug-resistant Pseudomonas aeruginosa. Int J Nanomedicine 2019;14(1):1469-1487. [Google Scholar] | [Crossref]
35. Maklakova M, Villarreal-Gomez LJ, Nefedova E, Shkil N, Pestryakov A, Bogdanchikova N. Role of biofilm formation in the drop of bacterial resistance to antibiotics after animal therapy with silver nanoparticles. ACS Appl Nano Mater 2024;7(14):16553-16563. [Google Scholar] | [Crossref]
36. Mohanta YK, Chakrabartty I, Mishra AK, Chopra H, Mahanta S, Avula SK, Sharma N. Nanotechnology in combating biofilm:a smart and promising therapeutic strategy. Front Microbiol 2023;13(1):1028086. [Google Scholar] | [Crossref]
37. Crisan MC, Pandrea SL, Matros L, Mocan T, Mocan L. In vitro antimicrobial activity of silver nanoparticles against selected Gram-negative and Gram-positive pathogens. Med Pharm Rep 2024;97(3):280. [Google Scholar] | [Crossref]
38. Mann R, Holmes A, McNeilly O, Cavaliere R, Sotiriou GA, Rice SA, Gunawan C. Evolution of biofilm-forming pathogenic bacteria in the presence of nanoparticles and antibiotic:adaptation phenomena and cross-resistance. J Nanobiotechnology 2021;19(1):291. [Google Scholar] | [Crossref]
39. Vazquez-Muñoz R, Bogdanchikova N, Huerta-Saquero A. Beyond the nanomaterials approach:influence of culture conditions on the stability and antimicrobial activity of silver nanoparticles. ACS Omega 2020;5(44):28441-28451. [Google Scholar] | [Crossref]
40. Soares JM, Yakovlev VV, Blanco KC, Bagnato VS. Photodynamic inactivation and its effects on the heterogeneity of bacterial resistance. Sci Rep 2024;14(1):28268. [Google Scholar] | [Crossref]
41. Lavoie T, Daffinee KE, Vicent ML, LaPlante KL. Staphylococcus biofilm dynamics and antibiotic resistance:insights into biofilm stages, zeta potential dynamics, and antibiotic susceptibility. Microbiol Spectr 2025;13(5):e02915-24. [Google Scholar] | [Crossref]
42. Frei A, Verderosa AD, Elliott AG, Zuegg J, Blaskovich MAT. Metals to combat antimicrobial resistance. Nat Rev Chem 2023;7(3):202-224. [Google Scholar] | [Crossref]
43. Mahfouz AM, Eraqi WA, El Hifnawi HNED, Shawky AED, Samir R, Ramadan MA. Genetic determinants of silver nanoparticle resistance and the impact of gamma irradiation on nanoparticle stability. BMC Microbiol 2025;25(1):18. [Google Scholar] | [Crossref]
44. Ansharieta R, Plumeriastuti H, Effendi MH. Genetic identification of shiga toxin encoding gene from cases of multidrug resistance (MDR) Escherichia coli isolated from raw milk. Trop. Anim. Sci. J 2021;44((1)):10-15. [Google Scholar] | [Crossref]
45. Ferreira AM, Vikulina A, Loughlin M, Volodkin D. How similar is the antibacterial activity of silver nanoparticles coated with different capping agents?. RSC Adv 2023;13(16):10542-10555. [Google Scholar] | [Crossref]
46. Bélteky P, Rónavári A, Igaz N, Szerencsés B, Tóth IY, Pfeiffer I, Kiricsi M, Kónya Z. Silver nanoparticles:aggregation behavior in biorelevant conditions and its impact on biological activity. Int J Nanomedicine 2019;14(1):667-687. [Google Scholar] | [Crossref]
47. Nejatpour M, Bayındır O, Duru P, Torabfam M, Meriç C, Kurt H, Yuce M, Bayazıt MK. Microwave-fluidic continuous manufacturing of ultrasmall silver nanoparticles in a polycaprolactone matrix as antibacterial coatings. ACS Omega 2025;10(18):18213-18224. [Google Scholar] | [Crossref]
48. Dove AS, Dzurny DI, Dees WR, Qin N, Rodriguez CCN, Alt LA, Czyż DM. Silver nanoparticles enhance the efficacy of aminoglycosides against antibiotic-resistant bacteria. Front Microbiol 2023;13(1):1064095. [Google Scholar] | [Crossref]
49. Niyonshuti II, Krishnamurthi VR, Okyere D, Song L, Benamara M, Tong X, Wang Y, Chen J. Polydopamine surface coating synergizes the antimicrobial activity of silver nanoparticles. ACS Appl Mater Interfaces 2020;12((36)):40067-40077. [Google Scholar] | [Crossref]
50. Trzcińska-Wencel J, Wypij M, Rai M, Golińska P. Biogenic nanosilver bearing antimicrobial and antibiofilm activities and its potential for application in agriculture and industry. Front Microbiol 2023;14(1):1125685. [Google Scholar] | [Crossref]
51. Tufail MS, Liaqat I, Andleeb S, Naseem S, Zafar U, Sadiqa A, Liaqat I, Ali NM, Bibi A, Arshad N, Saleem G. Biogenic synthesis, characterization and antibacterial properties of silver nanoparticles against human pathogens. J Oleo Sci 2022;71(2):257-265. [Google Scholar] | [Crossref]
52. Rana N, Banu AN, Kumar B, Singh SK, Abdel-Razik NE, Jalal NA, Bantun F, Vamanu E, Singh MP. Phytofabrication, characterization of silver nanoparticles using Hippophae rhamnoides berries extract and their biological activities. Front Microbiol 2024;15(1):1399937. [Google Scholar] | [Crossref]
53. Abbas G, Mustafa A, Iqbal TA, Iqbal A, Hassan M, Abbas S, Shaukat B. Current prospects of nanotechnology uses in animal production and its future scenario. Pak J Sci 2022;74(3):203-222. [Google Scholar] | [Crossref]
54. Eleraky NE, Allam A, Hassan SB, Omar MM. Nanomedicine fight against antibacterial resistance:an overview of the recent pharmaceutical innovations. Pharmaceutics 2020;12(2):142. [Google Scholar] | [Crossref]
55. Melese M, Abdu B, Fentahun S, Girma S, Genobaye I, Demssie E. Review on addressing antimicrobial resistance in livestock through a One Health approach. Am J Zool 2025;8(4):85-92. [Google Scholar] | [Crossref]
56. Putra ARS, Effendi MH, Koesdarto S, Tyasningsih W. Molecular identification of extended spectrum beta-lactamase (ESBL) producing Escherichia coli isolated from dairy cows in East Java Province, Indonesia. Indian Vet J 2019;96(10):26-30. [Google Scholar] | [Crossref]
57. Skandalis N, Maeusli M, Papafotis D, Miller S, Lee B, Theologidis I, Luna B. Environmental spread of antibiotic resistance. Antibiotics 2021;10(6):640. [Google Scholar] | [Crossref]
58. Wibisono FJ, Sumiarto B, Untari T, Effendi MH, Permatasari DA, Witaningrum AM. The presence of extended-spectrum beta-lactamases (ESBL) producing Escherichia colion layer chicken farms in Blitar Area, Indonesia. Biodiversitas 2020;21(6):2667-2671. [Google Scholar] | [Crossref]
59. Al-Khalaifah H, Rahman MH, Al-Surrayai T, Al-Dhumair A, Al-Hasan M. A One-Health perspective of antimicrobial resistance (AMR):human, animals and environmental health. Life 2025;15(10):1598. [Google Scholar] | [Crossref]
60. Sadia H, Adil M, Nasir MW, Nawaz A, Tariq A, Tariq I, Afghan SUD. Global strategies for combating antimicrobial resistance through the One Health approach:a mini review. Open Access Public Health Health Adm Rev 2025;4(1):60-71. [Google Scholar] | [Crossref]